Sign In
News Digest /
Income Statements
Income Statements
08:11am, Tuesday, Aug 12, 2025
Snapshot - Adverum Biotechnologies, Inc. (NASDAQ: ADVM)
What's happening inside the company
- Advancing lead gene‑therapy candidate ixoberogene soroparvovec (Ixo‑vec): ARTEMIS Phase 3 initiated Feb 2025; enrollment expected complete Q1 2026; top‑line ARTEMIS data expected H1 2027.
- LUNA Phase 2 ...
08:09am, Tuesday, Aug 12, 2025
Korro Bio, Inc. (NASDAQ: FREQ) - quick financial & operational read
Context: The company (formerly Frequency Therapeutics) is a clinical‑stage RNA‑editing biotech that completed a reverse merger in Nov 2023. This note summarizes what's happening internally and the main positives and negatives fro...
08:09am, Tuesday, Aug 12, 2025
Centessa Pharmaceuticals plc (NASDAQ: CNTA) - quick inside look
What's happening inside
* Management has pivoted capital and focus toward its OX2R (orexin receptor 2) agonist franchise (ORX750, ORX142, ORX489) after discontinuing several prior programs (SerpinPC and LB101).
* The company out‑lice...
08:08am, Tuesday, Aug 12, 2025
Climb Bio, Inc. (NASDAQ: ELYM)
Short take - Climb Bio is a clinical‑stage immunology biotech that scaled materially in mid‑2024 (Tenet acquisition) and early‑2025 (Mabworks license). Financials reflect the shift from a one‑time acquisition charge in 2024 to active clinical and licensing spend in ...
08:07am, Tuesday, Aug 12, 2025
Snapshot - Passage Bio, Inc. (PASG) (NASDAQ)
What's happening inside: the company executed a major restructuring in Jan 2025 (≈55% workforce reduction) and ceased Hopewell lab operations, out‑licensed several pediatric lysosomal programs to Gemma, and is concentrating resources on its lead clinic...
08:05am, Tuesday, Aug 12, 2025
Zenas BioPharma, Inc. (NASDAQ: ZBIO) - quick read on what's happening inside
The company is executing an expensive, accelerated clinical and pre-commercial build for its lead drug obexelimab while monetizing regional rights (Zai, Tenacia, BMS). Cash and liquid securities are healthy today, but bu...
08:04am, Tuesday, Aug 12, 2025
TScan Therapeutics, Inc. (NYSE: TCRX) - Quick read on what's happening inside
Short summary: the company is stepping up R&D and converting collaboration activity (Amgen) into recognitions of revenue while continuing to burn cash. Management says current resources fund operations into Q1 2027, but...
08:03am, Tuesday, Aug 12, 2025
Sable Offshore Corp. (NYSE: SOC) - Quick operational & income-statement snapshot
What's happening inside: production was restarted (May 15, 2025) and oil began flowing from six wells to onshore storage, the company raised equity in May 2025, but the restart accelerated the Senior Secured Term Lo...
08:02am, Tuesday, Aug 12, 2025
Grace Therapeutics, Inc. (NASDAQ: ACST) - Q1 (quarter ended June 30, 2025) snapshot
What's happening inside: management has pivoted to focus on the lead asset GTx‑104, completed the Phase 3 STRIVE‑ON program, submitted an NDA for GTx‑104 on June 25, 2025, and raised a material private placement i...
08:01am, Tuesday, Aug 12, 2025
Snapshot - Mereo BioPharma Group plc (NASDAQ: MREO)
What's happening inside: the company is advancing late‑stage rare‑disease programs (setrusumab and alvelestat), progressing Phase 3 activity with partner Ultragenyx, converting debt to equity to reduce interest burden, and recognizing a small li...
07:03am, Tuesday, Aug 12, 2025
DarioHealth Corp. (NASDAQ: DRIO) - Q2 2025 executive snapshot
What's happening: management is cutting operating costs and integrating acquisitions while leaning on a new Callodine credit facility ($32.5M drawn at close) to fund growth. Gross margins improved, but the company remains unprofitable,...
07:02am, Tuesday, Aug 12, 2025
Snapshot - Liquidia Corporation (NASDAQ: LQDA)
What's happening inside: FDA approved YUTREPIA on May 23, 2025 and Liquidia commercially launched it on June 2, 2025. The company has moved from R&D focus into commercialization (hiring, inventory build, sales shipments) and drew additional funding u...
07:01am, Tuesday, Aug 12, 2025
NeurAxis, Inc. (NASDAQ: NRXS) - Q2 2025 quick read
Key points & statistics
* Net sales Q2 2025: $894,086 (up 46.2% YoY from $611,500).
* Net sales six months 2025: $1,789,741 (up 42.3% YoY).
* Gross profit Q2 2025: $747,443; gross margin Q2 2025: 83.6% (down from 88.0% in Q2 2024).
* Cost of good...
07:01am, Tuesday, Aug 12, 2025
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) - quick reality check
Milestone is a clinical-stage cardio‑pharma company focused on etripamil (CARDAMYST). Management received a March 2025 CRL (CMC/manufacturing nitrosamine questions), submitted a response that the FDA accepted, and the agency set ...
06:21pm, Monday, Aug 11, 2025
Monroe Capital Corporation (NASDAQ: MRCC) - Quick read on "what's happening inside"
Snapshot / what changed in Q2 2025
* Total investments (fair value): $367,700,000 (down from $457,048,000 at 12/31/24).
* Total assets: $394,617,000; Total liabilities: $215,025,000; Net assets: $179,592,000.
* Ne...
06:19pm, Monday, Aug 11, 2025
Synchronoss Technologies, Inc. (NASDAQ: SNCR) - concise operational and income-statement brief from the Form 10‑Q for the quarter ended June 30, 2025.
Quick take
* Company is a white‑label cloud/software provider (Synchronoss Personal Cloud) with most revenue subscription‑based and heavily teleco...
06:19pm, Monday, Aug 11, 2025
Humacyte, Inc. (NASDAQ: AHAC) - Quick read on what's happening inside
Snapshot / what changed this quarter
- FDA approval and U.S. commercial launch of Symvess; first commercial shipments began March 2025.
- Revenue has started but remains very small: product and contract sales only began in 2025...
06:18pm, Monday, Aug 11, 2025
Snapshot - GSR III Acquisition Corp. (NASDAQ: GSRTU)
What's happening inside: the company is a blank‑check (SPAC) vehicle that completed an IPO, holds roughly $236.3 million in a trust account earning interest, has signed a Business Combination Agreement with Terra Innovatum (April 21, 2025), and...
06:17pm, Monday, Aug 11, 2025
SmartFinancial Q2: Loan, deposit growth drives higher NII/NIM and profits; provisions, expenses rise
SmartFinancial, Inc. (NASDAQ: SMBK) - Quick internal read
What's happening inside
SmartFinancial is growing loans and deposits aggressively year‑to‑date, translating higher loan yields into materially higher net interest income and improved margins. Profitability is up (quarter and YTD) while cre...
06:16pm, Monday, Aug 11, 2025
GrowGeneration Corp. (OTCBB: GRWG) - Q2 2025 snapshot
Inside the company: management completed a major restructuring (store closures, cost cuts), closed/ consolidated underperforming locations, acquired Viagrow (June 6, 2025), and is remediating a material internal-control weakness in its MMI (St...
06:15pm, Monday, Aug 11, 2025
Quick take - Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI)
Maravai is undergoing a painful near-term reset: revenue and margins have fallen materially, management recorded multi‑million goodwill charges, and the company announced a major cost-reduction and workforce plan while completing two...
06:14pm, Monday, Aug 11, 2025
Quick note on the company
Plug Power Inc. (NASDAQ: PLUG) - Q2 2025 10‑Q snapshot. Management is executing a cash-preservation plan (2025 Restructuring), raising financing (March equity offering, May 15.00% secured debenture) and pursuing DOE loan guarantees while continuing to scale electrolyzers...
06:13pm, Monday, Aug 11, 2025
Nauticus Robotics, Inc. (NASDAQ: KITT) - quick read on what's happening inside the company.
Snapshot
Nauticus has accelerated commercial activity in H1 2025, driven by the March 20, 2025 acquisition of SeaTrepid and increased ROV/service deployments. That growth coincides with heavy financing, la...
06:13pm, Monday, Aug 11, 2025
Snapshot - Quipt Home Medical Corp. (NASDAQ: QIPT)
What's happening inside the company
* Quipt is seeing modest revenue pressure while generating strong operating cash flow. Management is cutting costs, issuing equity incentives and continuing M&A (closed Mediserve on July 1, 2025 for ≈ $2.6M).
*...
06:12pm, Monday, Aug 11, 2025
Gyre Therapeutics, Inc. (NASDAQ: CBIO) - Quick read on what's happening inside
Short version: the company is transitioning from legacy Catalyst operations into a China-focused commercial biopharma (Gyre Pharmaceuticals). It launched two new products in 2025 (Contiva in March, Etorel in June), rai...
06:11pm, Monday, Aug 11, 2025
NET Power Inc. (NYSE: NPWR) - Q2 2025 snapshot (Form 10‑Q)
What's happening inside the company
- Management paused further long‑lead equipment releases for Project Permian and has begun a value‑engineering exercise; earliest commercial online date if successful: 2029.
- The company accelerated va...
06:10pm, Monday, Aug 11, 2025
Turning Point Brands, Inc. (TPB) - NYSE
Snapshot - what's happening inside the company
* Revenue acceleration driven by Stoker's (modern oral) while Zig‑Zag declines; management redeployed CDS into a JV (GWO) on Jan 2, 2025.
* Balance sheet strengthened by a large debt refinancing (issued 2032 No...
06:09pm, Monday, Aug 11, 2025
Snapshot - WideOpenWest, Inc. (NYSE: WOW)
Quick read: WOW reported Q2 2025 results showing continued pressure on top-line and profitability driven by subscriber declines and rising interest costs, while broadband (HSD) demand and ARPU improvements offer partial offset. A proposed merger (Aug 11, ...
06:08pm, Monday, Aug 11, 2025
Quick read - what's happening inside Spirit Aviation Holdings, Inc. (NASDAQ: SAVE)
Spirit emerged from Chapter 11 on March 12, 2025 and applied fresh-start accounting. The restructuring materially reduced pre‑petition debt and created a new capital structure (new common stock and warrants issued)...
06:07pm, Monday, Aug 11, 2025
Horizon Space Acquisition I Corp. (NASDAQ: HSPOU) - Quick take
This is a blank‑check (SPAC) that has not commenced operating activities. Its balance sheet is dominated by a Trust Account holding funds for a planned business combination. The company reported positive GAAP net income for the quarte...
06:06pm, Monday, Aug 11, 2025
Microvast Holdings, Inc. (NASDAQ: MVST)
Quick read: Q2 shows improving core operations and cash generation but a very large non‑cash hit from fair‑value accounting (convertible loan/warrants) creates a big headline net loss, plus liquidity and governance risks remain material.
Key facts & number...
06:05pm, Monday, Aug 11, 2025
Quick take - Primis Financial Corp. (FRST) (OTCBB: FRST)
What's happening inside: management is reshaping the business (deconsolidation and partial sale of Panacea Financial Holdings, faster mortgage-warehouse growth, stock buyback activity) while absorbing credit losses from legacy Consumer Prog...
06:04pm, Monday, Aug 11, 2025
Hallador Energy Company (HNRG) - NASDAQ
Quick take: Management is executing a shift from a coal-centric producer toward an integrated independent power producer centered on the Merom plant. Results improved in Q2 2025: the company returned to profit, increased cash and completed a $35.0M prepaid ...
06:03pm, Monday, Aug 11, 2025
Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Quick internal update & income-statement highlights
What's happening inside
* BLA & regulatory: Company completed rolling BLA (Dec 2024); FDA accepted and granted Priority Review. In May 2025 FDA performed PLI and issued Form 483 observations that Capr...
06:02pm, Monday, Aug 11, 2025
Bally's Corporation (NYSE: BALY) - quick read on what's happening inside
Short take: the company completed the Queen merger (Feb 7, 2025), expanded scale and international holdings (notably a large stake in Intralot), and reported modest revenue growth but a very large GAAP loss in Q2 2025 driven...
06:02pm, Monday, Aug 11, 2025
Richtech Robotics Inc. (NASDAQ: RR) - Quick internal snapshot
The company is executing a deliberate shift from one‑time product sales toward a Robots‑as‑a‑Service (RaaS) model while scaling operations (new HQ/building purchase, expanded R&D, hiring). Management raised material capital via an ATM ...
06:01pm, Monday, Aug 11, 2025
Dominari Holdings Inc. (NASDAQ: AIKI) - Q2 2025 highlights from the Form 10‑Q (period ended June 30, 2025). Quick, straight summary of what's happening inside the company and what the income statement says - positives and negatives first, then the key facts you need to know.
What's driving the qu...
05:31pm, Monday, Aug 11, 2025
Hillenbrand posts tiny Q3 profit; revenue, adjusted EBITDA fall as TerraSource sale boosts liquidity
Hillenbrand (NYSE: HI) - quick take
What's happening inside: management completed the Milacron divestiture (Mar 31, 2025), retained a 48.74% equity stake, and recorded a loss on the transaction. Results for the quarter improved versus heavy one‑time charges in FY24 (no repeat goodwill/indefinite‑...
05:30pm, Monday, Aug 11, 2025
Snapshot - Xenon Pharmaceuticals Inc. (NASDAQ: XENE)
All figures below are taken from Xenon's Form 10‑Q for the quarter ended June 30, 2025 (amounts shown in the filing are expressed in thousands of U.S. dollars unless noted).
What's happening inside the company
* Xenon is heavily ramping late‑st...
05:29pm, Monday, Aug 11, 2025
Snapshot - Ouster, Inc. (NYSE: OUST)
What's happening inside the company
* Revenue momentum: Q2 2025 revenue $35,049,000, up 30% year-over-year; six‑month revenue $67,681,000, up 28% YoY.
* Improved gross margin: Q2 gross profit $15,842,000; gross margin 45% (vs. 34% in Q2 2024).
* Losses narrowi...
